Intrauterine programming

Document Type: Review Article

Authors

1 Endocrine Physiology Research Center, Research Institute for Endocrine Sciences, Shahid-Beheshti University of Medical Sciences, Tehran, Iran.

2 Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid-Beheshti University of Medical Sciences, Tehran, Iran

Abstract

In mammals, the intrauterine condition has an important role in the development of fetal physiological systems in later life. Suboptimal maternal environment can alter the regulatory pathways that determine the normal development of the fetus in utero, which in post-natal life may render the individual more susceptible to cardiovascular or metabolic adult-life diseases. Changes in the intrauterine availability of nutrients, oxygen and hormones can change the fetal tissue developmental regulatory planning, which occurs genomically and non-genomically and can cause permanent structural and functional changes in the systems, leading to diseases in early years of life and those that particularly become overt in adulthood. In this review we take a brief look at the main elements which program the fetal system development and consequently induce a crucial impact on the cardiovascular, nervous and hormonal systems in adulthood.

Keywords


1.   Bertram CE, Hanson MA. Animal models and programming of the metabolic syndrome. Br Med Bull 2001; 60: 103-121

2.   Fowden AL, Giussani DA, Forhead AJ. Intrauterine programming of physiological systems: Causes and consequences. Physiology 2006; 21:29-37.

3.   Fowden AL, Forhead AJ. Endocrine mechanisms of intrauterine programming. Reproduction 2004; 127:515-526.

4.   Fernandez-Twinn DS, Ozanne SE. Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome. Physiol Behav 2006; 88:234-243.

5.   Langley-Evans SC. Fetal programming of CVD and renal disease: animal models and mechanistic considerations. Proc Nutr Soc 2013; 72:317-325.

6.   Eberle C, Ament C. Diabetic and metabolic programming: mechanisms altering the intrauterine milieu. ISRN Pediatr 2012; 2012:1-11.

7.   Zahediasl S. Importance of thyroid hormones in intrauterine programming. Int J Endocrinol Metab 2010; 8:186-187.

8.   Langley-Evans SC, McMullen S. Developmental Origins of Adult Disease. Med Princ Pract 2010; 19:87-98.

9.   Kwong WY, Wild AE, Roberts P, Willis AC, Fleming TP. Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Development 2000; 127:4195-4202.

10. Barker DJP. The developmental origins of chronic adult disease. Acta Paediatr Suppl 2004; 93:26-33.

11. Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull 2001; 60:5-20.

12. Gluckman PD, Hanson MA. Maternal constraint of fetal growth and its consequences. Semin Fetal Neonatal Med 2004; 9:419-425.

13. Jones RH, Ozanne SE. Fetal programming of glucose-insulin metabolism. Mol Cell Endocrinol 2009; 297:4-9.

14. Christian P, Stewart CP. Maternal micronutrient deficiency, fetal development, and the risk of chronic disease. J Nutr 2010; 140:437-445.

15. Sola-Visner M. Cardiovascular disease and weight ... at birth. Blood 2011; 118:1439-1441.

16. Ponzio BF, Carvalho MH, Fortes ZB, do Carmo Franco M. Implications of maternal nutrient restriction in transgenerational programming of hypertension and endothelial dysfunction across F1-F3 offspring. Life Sci 2012; 90:571-577.

17. Torrens C, Hanson MA, Gluckman PD, Vickers MH. Maternal undernutrition leads to endothelial dysfunction in adult male rat offspring independent of postnatal diet. Br J Nutr 2009; 101:27-33.

18. Fowden AL, Hill DJ. Intra-uterine programming of the endocrine pancreas. Br Med Bull 2001; 60:123-142.

19. Karbalaei N, Ghasemi A, Faraji F, Zahediasl S. Comparison of the effect of maternal hypothyroidism on carbohydrate metabolism in young and aged male offspring in rats. Scand J Clin Lab Invest 2013; 73:87-94.

20. Pinheiro AR, Salvucci ID, Aguila MB, Mandarim-de-Lacerda CA. Protein restriction during gestation and/or lactation causes adverse transgenerational effects on biometry and glucose metabolism in F1 and F2 progenies of rats. Clin Sci 2008; 114:381-392.

21. Hawkins P, Steyn C, McGarrigle HH, Saito T, Ozaki T, Stratford LL, et al Effect of maternal nutrient restriction in early gestation on development of the hypothalamic-pituitary-adrenal axis in fetal sheep at 0.8-0.9 of gestation. J Endocrinol 1999; 163:553-561.

22. Bertram C, Khan O, Ohri S, Phillips DI, Matthews SG, Hanson MA. Transgenerational effects of prenatal nutrient restriction on cardiovascular and hypothalamic-pituitary-adrenal function. J Physiol 2008; 586:2217-2229.

23. Gluckman PD, Cutfield W, Harding JE, Milner D, Jensen E, Woodhall S, et al. Metabolic consequences of intrauterine growth retardation. Acta Paediatr Suppl 1996; 417: 3-6; discussion 7.

24. Torrens C, Poston L, Hanson MA. Transmission of raised blood pressure and endothelial dysfunction to the F2 generation induced by maternal protein restriction in the F0, in the absence of dietary challenge in the F1 generation. Br J Nutr 2008; 100:760-766.

25. Painter RC, Osmond C, Gluckman P, Hanson M, Phillips DI, Roseboom TJ. Transgenerational effects of prenatal exposure to the Dutch famine on neonatal adiposity and health in later life. BJOG 2008; 115:1243-1249.

26. Tuchscherer M, Otten W, Kanitz E, Grabner M, Tuchscherer A, Bellmann O, et al. Effects of inadequate maternal dietary protein: carbohydrate ratios during pregnancy on offspring immunity in pigs. BMC Vet Res 2012; 8:232-240.

27. Sathishkumar K, Balakrishnan M, Chinnathambi V, Gao H, Yallampalli C. Temporal alterations in vascular angiotensin receptors and vasomotor responses in offspring of protein-restricted rat dams. Am J Obstet Gynecol 2012; 206:507.e1-10.

28. Tsukuda K, Mogi M, Iwanami J, Min LJ, Jing F, Ohshima K, et al. Influence of angiotensin II type 1 receptor-associated protein on prenatal development and adult hypertension after maternal dietary protein restriction during pregnancy. J Am Soc Hypertens 2012; 6:324-330.

29. Gao H, Yallampalli U, Yallampalli C. Gestational protein restriction reduces expression of Hsd17b2 in rat placental labyrinth. Biol Reprod 2012; 87:68.

30. Lisboa PC, Fagundes AT, Denolato AT, Oliveira E, Bonomo IT, Alves SB, et al. Neonatal low-protein diet changes deiodinase activities and pituitary TSH response to TRH in adult rats. Exp Biol Med (Maywood) 2008; 233:57-63.

31. Lewis RM, Petry CJ, Ozanne SE, Hales CN. Effects of maternal iron restriction in the rat on blood pressure, glucose tolerance, and serum lipids in the 3-month-old offspring. Metabolism 2001; 50:562-567.

32. Jou MY, Lonnerdal B, Philipps AF. Maternal zinc restriction affects postnatal growth and glucose homeostasis in rat offspring differently depending upon adequacy of their nutrient intake. Pediatr Res 2012; 71:228-234.

33. Makhoul IR, Sammour RN, Diamond E, Shohat I, Tamir A, Shamir R. Selenium concentrations in maternal and umbilical cord blood at 24-42 weeks of gestation: basis for optimization of selenium supplementation to premature infants. Clin Nutr 2004; 23:373-381.

34. Rayman MP, Searle E, Kelly L, Johnsen S, Bodman-Smith K, Bath SC, et al. Effect of selenium on markers of risk of pre-eclampsia in UK pregnant women: a randomised, controlled pilot trial. Br J Nutr 2014; 112:99-111.

35. Kim J, Kim YJ, Lee R, Moon JH, Jo I. Serum levels of zinc, calcium, and iron are associated with the risk of preeclampsia in pregnant women. Nutr Res 2012; 32:764-769.

36. Hashemipour S, Ziaee A, Javadi A, Movahed F, Elmizadeh K, Javadi EH, et al. Effect of treatment of vitamin D deficiency and insufficiency during pregnancy on fetal growth indices and maternal weight gain: a randomized clinical trial. Eur J Obstet Gynecol Reprod Biol 2014; 172:15-19.

37. Aly YF, El Koumi MA, Abd El Rahman RN. Impact of maternal vitamin D status during pregnancy on the prevalence of neonatal vitamin D deficiency. Pediatr Rep 2013; 5:e6.

38. de Escobar GM, Obregon MJ, del Rey FE. Iodine deficiency and brain development in the first half of pregnancy. Public Health Nutr 2007; 10:1554-1570.

39. Patel J, Landers K, Li HK, Mortimer RH, Richard K. Delivery of maternal thyroid hormones to the fetus. Trends Endocrinol Metab 2011; 22:164-170.

40. Illsley NP, Caniggia I, Zamudio S. Placental metabolic reprogramming: do changes in the mix of energy-generating substrates modulate fetal growth? Int J Dev Biol 2010; 54:409-419.

41. Postigo L, Heredia G, Illsley NP, Torricos T, Dolan C, Echalar L, et al. Where the O2 goes to: preservation of human fetal oxygen delivery and consumption at high altitude. J Physiol 2009; 587:693-708.

42. Schneider H. Oxygenation of the placental-fetal unit in humans. Respir Physiol Neurobiol 2011; 178:51-58.

43. Murray AJ. Oxygen delivery and fetal-placental growth: beyond a question of supply and demand? Placenta 2012; 33 Suppl 2: e16-22.

44. Williams SJ, Hemmings DG, Mitchell JM, McMillen IC, Davidge ST. Effects of maternal hypoxia or nutrient restriction during pregnancy on endothelial function in adult male rat offspring. J Physiol 2005; 565:125-135.

45. Fowden AL. Endocrine Regulation of Fetal Growth. Reprod Fertil Dev 1995; 7:351-363.

46. Chang YP. Evidence for adverse effect of perinatal glucocorticoid use on the developing brain. Korean J Pediatr 2014; 57:101-109.

47. Marciniak B, Patro-Malysza J, Poniedzialek-Czajkowska E, Kimber-Trojnar Z, Leszczynska-Gorzelak B, Oleszczuk J. Glucocorticoids in pregnancy. Curr Pharm Biotechnol 2011; 12:750-757.

48. Khulan B, Drake AJ. Glucocorticoids as mediators of developmental programming effects. Best Pract Res Clin Endocrinol Metab 2012; 26:689-700.

49. Kamoun M, Mnif MF, Charfi N, Kacem FH, Naceur BB, Mnif F, et al. Adrenal diseases during pregnancy: pathophysiology, diagnosis and management strategies. Am J Med Sci 2014; 347:64-73.

50. Milner RD, Hill DJ. Fetal growth control: the role of insulin and related peptides. Clin Endocrinol (Oxf) 1984; 21:415-433.

51. Fowden AL. The insulin-like growth factors and feto-placental growth. Placenta 2003; 24:803-812.

52. Hill DJ, Duvillie B. Pancreatic development and adult diabetes. Pediatr Res 2000; 48:269-274.

53. Tang C, Marchand K, Lam L, Lux-Lantos V, Thyssen SM, Guo J, et al. Maternal taurine supplementation in rats partially prevents the adverse effects of early-life protein deprivation on beta-cell function and insulin sensitivity. Reproduction 2013; 145:609-620.

54. Snoeck A, Remacle C, Reusens B, Hoet JJ. Effect of a low protein diet during pregnancy on the fetal rat endocrine pancreas. Biol Neonate 1990; 57:107-118.

55. Farahani H, Ghasemi A, Roghani M, Zahediasl S. Effect of neonatal hypothyroidism on carbohydrate metabolism, insulin secretion, and pancreatic islets morphology of adult male offspring in rats. J Endocrinol Invest 2013; 36:44-49.

56. Farahani H, Ghasemi A, Roghani M, Zahediasl S. The effect of maternal hypothyroidism on the carbohydrate metabolism and insulin secretion of isolated islets in adult male offspring of rats. Horm Metab Res 2010; 42:792-797.

57. Karbalaei N, Ghasemi A, Hedayati M, Godini A, Zahediasl S. The possible mechanisms by which maternal hypothyroidism impairs insulin secretion in adult male offspring in rats. Exp Physiol 2014; 99:701-714.

58. Devaskar SU, Holekamp N, Marino N, Devaskar UP. Altered thyroidal states modulate the insulin receptor characteristics of the developing rabbit brain. Dev Pharmacol Ther 1986; 9:350-360.

59. Calvo R, Morreale de Escobar G, Escobar del Rey F, Obregon MJ. Maternal diabetes mellitus, a rat model for nonthyroidal illness: correction of hypothyroxinemia with thyroxine treatment does not improve fetal thyroid hormone status. Thyroid 1997; 7:79-87.

60. Sferruzzi-Perri AN, Owens JA, Pringle KG, Roberts CT. The neglected role of insulin-like growth factors in the maternal circulation regulating fetal growth. J Physiol 2011; 589:7-20.

61. Szinnai G. Genetics of normal and abnormal thyroid development in humans. Best Pract Res Clin Endocrinol Metab 2014; 28:133-150.

62. Zoeller RT, Rovet J. Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J Neuroendocrinol 2004; 16:809-818.